Physicochemical and physiological considerations for efficient nose-to-brain targeting

被引:99
作者
Bahadur, Shiv [1 ]
Pathak, Kamla [1 ]
机构
[1] Rajiv Acad Pharm, Dept Pharmaceut, Mathura 281001, Uttar Pradesh, India
关键词
brain targeting; intranasal administration; physicochemical properties; physiological factors; strategies; INTRANASAL DRUG-DELIVERY; NASAL ABSORPTION; SYSTEM; TRANSPORT; BIOAVAILABILITY; NANOPARTICLES; FORMULATION; CAVITY; ROUTE;
D O I
10.1517/17425247.2012.636801
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Nasal drug delivery that exploits the olfactory and trigeminal neuronal pathways to deliver drugs to the brain is being widely explored by pharmaceutical companies, for the delivery of challenging drugs. Low-molecular-weight and lipophilic drugs are effectively absorbed by the intranasal route for efficacious brain targeting; however, high-molecular-weight and hydrophilic drugs present challenges in intranasal delivery. Areas covered: The present review critically evaluates the physicochemical properties of drugs and formulation variables that influence brain targeting by the intranasal route. It also encompasses the influence of physiological factors of the nose that can influence absorption and the strategies utilized to increase nasal drug absorption. Expert opinion: The challenges of drug delivery to the brain can be overcome by chemical and pharmaceutical approaches; current research is focused on developing novel drug delivery systems for both local and systemic actions. Nose-to-brain targeting has vast potential for commercialization, as these systems allow the lowering of doses, by direct targeting of the active molecule that provides easy attainment of the effective concentration at the target site. Consequently, these systems are being explored for the delivery of biologically active molecules, to treat the ailments of the CNS and various proteins, amino acids and hormones.
引用
收藏
页码:19 / 31
页数:13
相关论文
共 65 条
[1]   In vitro polarized transport of L-phenylalanine in human nasal epithelium and partial characterization of the amino acid transporters involved [J].
Agu, R ;
Dang, HV ;
Jorissen, M ;
Willems, T ;
Vandoninck, S ;
Van Lint, J ;
Vandenheede, JV ;
Kinget, R ;
Verbeke, N .
PHARMACEUTICAL RESEARCH, 2003, 20 (08) :1125-1132
[2]   Strategy for effective brain drug delivery [J].
Alam, M. Intakhab ;
Beg, Sarwar ;
Samad, Abdus ;
Baboota, Sanjula ;
Kohli, Kanchan ;
Ali, Javed ;
Ahuja, Alka ;
Akbar, M. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 40 (05) :385-403
[3]  
ARORA P, 2002, DRUG DELIV TECH, V7, P5
[4]   Gold nanoparticles: opportunities and challenges in nanomedicine [J].
Arvizo, Rochelle ;
Bhattacharya, Resham ;
Mukherjee, Priyabrata .
EXPERT OPINION ON DRUG DELIVERY, 2010, 7 (06) :753-763
[5]   Delivery of therapeutic agents to the central nervous system: the problems and the possibilities [J].
Begley, DJ .
PHARMACOLOGY & THERAPEUTICS, 2004, 104 (01) :29-45
[6]   Effects of physicochemical properties and other factors on systemic nasal drug delivery [J].
Behl, CR ;
Pimplaskar, HK ;
Sileno, AP ;
deMeireles, J ;
Romeo, VD .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 29 (1-2) :89-116
[7]  
BERG MP, 2004, EUR J PHARM BIOPHARM, V58, P131
[8]   Bioavailability of intranasal drug delivery system [J].
Bhise, Satish Balakrishna ;
Yadav, Adhikrao Vyankatrao ;
Avachat, Amelia Makrand ;
Malayandi, Rajkumar .
ASIAN JOURNAL OF PHARMACEUTICS, 2008, 2 (04) :201-215
[9]   Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin [J].
Bhumkar, Devika R. ;
Joshi, Hrushikesh M. ;
Sastry, Murali ;
Pokharkar, Varsha B. .
PHARMACEUTICAL RESEARCH, 2007, 24 (08) :1415-1426
[10]   Distribution and clearance of bioadhesive formulations from the olfactory region in man: Effect of polymer type and nasal delivery device [J].
Charlton, S. ;
Jones, N. S. ;
Davis, S. S. ;
Illum, L. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 30 (3-4) :295-302